Duke Studying Why Some Cancers Become Resistant to Therapy
Duke Studying Why Some Cancers Become Resistant to Therapy
David G. Kirsch, MD, PhD, is leading a Duke Cancer Institute study on cancer biology and radiation response.
By understanding how cancers develop, how tumors respond to therapy, and how they become resistant to therapy, his team is working to develop new therapies that save lives.